000			02501na a2200265 4500
999			_c10383 _d10383
003			PC10383
005			20191017115550.0
008			130622s2013 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aFernández Alén, José _9418 _eNeurocirugía
100			_aCampollo Velarde, Jorge _92341 _eRadiodiagnóstico
100			_aLagares Gómez-Abascal, Alfonso _91756 _b _eNeurocirugía
100			_aDíez Lobato, Ramiro _9731 _eNeurocirugía
100			_aCastaño León, Ana María _92069 _eNeurocirugía
100			_aMartinez Perez, Rafael _91759 _eNeurocirugía
100			_aMartín Munárriz, Pablo _91761 _eNeurocirugía
100			_aParedes Sansinenea, Ígor _9311 _eNeurocirugía
245	0	0	_aFístulas durales arteriovenosas intracraneales. Experiencia con 81 casos y revisión de la literatura. _h[artículo]
260			_bNeurocirugía _c2013
300			_a24(4):141-51.
500			_aFormato Vancouver: Paredes I, Martínez-Pérez R, Munarriz PM, Castaño-León AM, Campollo J, Alén JF et al. Fístulas durales arteriovenosas intracraneales. Experiencia con 81 casos y revisión de la literatura. Neurocirugia (Astur). 2013 Jul-Aug;24(4):141-51.
501			_aPMID: 23582488
504			_aContiene 81 referencias
520			_aObjectives: To analyse the clinical, radiological and therapeutic variables of intracranial dural arteriovenous fistulae (DAVF) treated at our institution, and to assess the validity of the Borden and Cognard classifications and their correlation with the presenting symptoms. Material and methods: The DAVF identified were retrospectively analysed. They were classified according to their location, drainage pattern and the Borden and Cognard classifications. We recorded the different treatments, their complications and efficacy. Results: There were 81 DAVF identified between 1975 and 2012. The cavernous sinus (CS) location was the most frequent one. The Borden and Cognard classifications showed an interobsercrer Kappa index of 0.72 and 0.76 respectively. The odds ratio of aggressive presentation in the presence of cortical venous drainage (CVD) was 19.3 (2.8-132.4). No location, once adjusted by venous drainage pattern, showed significant association with an aggressive presentation. Endovascular transarterial treatment of cavernous sinus DAVF achieved symptomatic improvement of 78%, with a complication rate of 5%. The DAVF of non-CS locations, with CVD, treated surgically were angiographically shown cured in 100% of the cases, with no treatment-related complications. Conclusions: The presence of CVD was significantly associated with aggressive presentations. The Borden and Cognard classifications showed little interobserver variability. Endovascular treatment for CS DAVF is safe and relatively effective. Surgical treatment of non-CS DAVF with CVD is safe, effective and the first choice treatment in our environment.
710			_9312 _aServicio de Neurocirugía
710			_9462 _aServicio de Radiodiagnóstico
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc10383.pdf _ySolicitar documento
942			_n0 _2ddc _cART